Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT02571634
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients ASA(American Society of Anesthesiologist physical classification system) I-III
* 18 years of age and older Referred for lumbar facet RFA (radio-frequency ablation) by Womack IPMC (Interdisciplinary Pain Management Center)
Exclusion Criteria:
* Known allergy to Fentanyl or naloxone
* Diagnoses of allergic rhinitis with active rhinorrhea
* Pregnant or Breastfeeding
* Asthma or COPD (chronic obstructive pulmonary disease) that requires frequent rescue medications.
* Hepatic insufficiency with abnormal liver enzymes
* Noted decreased mental function
* Heart rate under 50 or BP below 90 systolic and/or 60 diastolic
* Myasthenia gravis diagnoses
* Acute narrow angle glaucoma
* Allergy to meperidine
* On medications with a known dangerous drug interactions to Fentanyl
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02571634
Study Brief:
Protocol Section:
NCT02571634